Log In
Print
BCIQ
Print
Print this Print this
 

AVI-7537

  Manage Alerts
Collapse Summary General Information
Company Sarepta Therapeutics Inc.
DescriptionSingle oligomer nucleic acid analog based on morpholino-modified phosphorodiamidate oligomers (PMO) antisense chemistry
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication DetailsTreat Ebola infection
Regulatory Designation

U.S. - Fast Track (Treat Ebola infection)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today